Brief: Roquefort Therapeutics Out-Licenses MK Cell Patents For Up To $25 Mln
03/11/2025 07:33
Nov 3 (Reuters) - Roquefort Therapeutics PLC ROQ.L: OUT-LICENSES MK CELL PATENTS FOR UP TO $25 MILLION LYRAMID SALE LONGSTOP DATE EXTENDED TO 31 JANUARY 2026 ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts